TESARO, Inc. Balance Sheet | Understand Stock

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q3 FY2018 As of Sep 30, 2018	Q2 FY2018 As of Jun 30, 2018	Q1 FY2018 As of Mar 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q3 FY2017 As of Sep 30, 2017	Q2 FY2017 As of Jun 30, 2017	Q1 FY2017 As of Mar 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q3 FY2016 As of Sep 30, 2016	Q2 FY2016 As of Jun 30, 2016	Q1 FY2016 As of Mar 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q3 FY2015 As of Sep 30, 2015	Q2 FY2015 As of Jun 30, 2015	Q1 FY2015 As of Mar 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q3 FY2014 As of Sep 30, 2014	Q2 FY2014 As of Jun 30, 2014	Q1 FY2014 As of Mar 31, 2014	Q4 FY2013 As of Dec 31, 2013
Assets
Current assets:
Cash and cash equivalents
Accounts receivable
Inventories
Other current assets
Assets Held-for-sale, Not Part of Disposal Group, Current
Total current assets
Intangible assets, net
Property and equipment, net
Restricted cash
Other assets
Total assets
Liabilities and stockholders’ equity (deficit)
Current liabilities:
Accounts payable
Accrued expenses
Accrued milestone obligation
Deferred revenue, current
Other current liabilities
Total current liabilities
Customer Deposits, Noncurrent
Convertible notes, net
Long-term debt, net
Deferred revenue, non-current
Other non-current liabilities
Total liabilities
Stockholders' equity (deficit):
Common stock, $0.0001 par value; 100,000,000 shares authorized at both September 30, 2018 and December 31, 2017; 55,034,990 and 54,464,039 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders' equity (deficit)
Total liabilities and stockholders' equity (deficit)

Comments